{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:44:58Z","timestamp":1790232298605,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,9,24]],"date-time":"2013-09-24T00:00:00Z","timestamp":1379980800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.5"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s10549-013-2697-5","type":"journal-article","created":{"date-parts":[[2013,9,23]],"date-time":"2013-09-23T06:28:24Z","timestamp":1379917704000},"page":"461-470","source":"Crossref","is-referenced-by-count":41,"title":["Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancer"],"prefix":"10.1007","volume":"141","author":[{"given":"Hope S.","family":"Rugo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Brufsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne Ulcickas","family":"Yood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debu","family":"Tripathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musa","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bongin","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oyewale O.","family":"Abidoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise A.","family":"Yardley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,24]]},"reference":[{"key":"2697_CR1","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1200\/JCO.2005.04.5799","volume":"24","author":"NA Bickell","year":"2006","unstructured":"Bickell NA, Wang JJ, Oluwole S, Schrag D, Godfrey H, Hiotis K, Mendez J, Guth AA (2006) Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol 24:1357\u20131362","journal-title":"J Clin Oncol"},{"key":"2697_CR2","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","volume":"295","author":"LA Carey","year":"2006","unstructured":"Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492\u20132502","journal-title":"JAMA"},{"key":"2697_CR3","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1200\/JCO.2008.19.6873","volume":"27","author":"D Huo","year":"2009","unstructured":"Huo D, Ikpatt F, Khramtsov A, Dangou JM, Nanda R, Dignam J, Zhang B, Grushko T, Zhang C, Oluwasola O, Malaka D, Malami S, Odetunde A, Adeoye AO, Iyare F, Falusi A, Perou CM, Olopade OI (2009) Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol 27:4515\u20134521","journal-title":"J Clin Oncol"},{"key":"2697_CR4","doi-asserted-by":"crossref","first-page":"R18","DOI":"10.1186\/bcr2242","volume":"11","author":"LA Stead","year":"2009","unstructured":"Stead LA, Lash TL, Sobieraj JE, Chi DD, Westrup JL, Charlot M, Blanchard RA, Lee JC, King TC, Rosenberg CL (2009) Triple-negative breast cancers are increased in black women regardless of age or body mass index. Breast Cancer Res 11:R18","journal-title":"Breast Cancer Res"},{"key":"2697_CR5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1476-072X-9-35","volume":"9","author":"N Tian","year":"2010","unstructured":"Tian N, Goovaerts P, Zhan FB, Wilson JG (2010) Identification of racial disparities in breast cancer mortality: does scale matter? Int J Health Geogr 9:35","journal-title":"Int J Health Geogr"},{"key":"2697_CR6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10549-007-9560-5","volume":"107","author":"A Stark","year":"2008","unstructured":"Stark A, Kapke A, Schultz D, Brown R, Linden M, Raju U (2008) Advanced stages and poorly differentiated grade are associated with an increased risk of HER2\/neu positive breast carcinoma only in white women: findings from a prospective cohort study of African-American and white-American women. Breast Cancer Res Treat 107:405\u2013414","journal-title":"Breast Cancer Res Treat"},{"key":"2697_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1634\/theoncologist.10-1-1","volume":"10","author":"LA Newman","year":"2005","unstructured":"Newman LA (2005) Breast cancer in African-American women. Oncologist 10:1\u201314","journal-title":"Oncologist"},{"key":"2697_CR8","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/bcr2261","volume":"11","author":"ML Kwan","year":"2009","unstructured":"Kwan ML, Kushi LH, Weltzien E, Maring B, Kutner SE, Fulton RS, Lee MM, Ambrosone CB, Caan BJ (2009) Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res 11:R31","journal-title":"Breast Cancer Res"},{"key":"2697_CR9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/cncr.11019","volume":"97","author":"OI Olopade","year":"2003","unstructured":"Olopade OI, Fackenthal JD, Dunston G, Tainsky MA, Collins F, Whitfield-Broome C (2003) Breast cancer genetics in African Americans. Cancer 97:236\u2013245","journal-title":"Cancer"},{"key":"2697_CR10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","volume":"235","author":"DJ Slamon","year":"1987","unstructured":"Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene. Science 235:177\u2013182","journal-title":"Science"},{"key":"2697_CR11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ijc.2910490504","volume":"49","author":"O-P Kallioniemi","year":"1991","unstructured":"Kallioniemi O-P, Holli K, Visakorpi V, Koivula T, Helin HH, Isola JJ (1991) Association of C-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer. Int J Cancer 49:650\u2013655","journal-title":"Int J Cancer"},{"key":"2697_CR12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2165\/00024669-200302030-00002","volume":"2","author":"L Estevez","year":"2003","unstructured":"Estevez L, Seidman A (2003) HER2-positive breast cancer: incidence, prognosis, and treatment options. Am J Cancer 2:169\u2013179","journal-title":"Am J Cancer"},{"key":"2697_CR13","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1158\/1078-0432.CCR-10-2962","volume":"17","author":"AM Brufsky","year":"2011","unstructured":"Brufsky AM, Mayer M, Rugo HS, Kaufman PA, Tan-Chiu E, Tripathy D, Tudor IC, Wang LI, Brammer MG, Shing M, Yood MU, Yardley DA (2011) Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHER. Clin Cancer Res 17:4834\u20134843","journal-title":"Clin Cancer Res"},{"key":"2697_CR14","unstructured":"National Cancer Institute (2006) Common terminology criteria for adverse events v3.0 (CTCAE). http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/ctcaev3.pdf . Accessed 28 March 2013"},{"key":"2697_CR15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2174\/157339912799424519","volume":"8","author":"L Vona-Davis","year":"2012","unstructured":"Vona-Davis L, Rose DP (2012) Type 2 diabetes and obesity metabolic interactions: common factors for breast cancer risk and novel approaches to prevention and therapy. Curr Diabetes Rev 8:116\u2013130","journal-title":"Curr Diabetes Rev"},{"key":"2697_CR16","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.amjmed.2010.04.020","volume":"123","author":"S Jolly","year":"2010","unstructured":"Jolly S, Vittinghoff E, Chattopadhyay A, Bibbins-Domingo K (2010) Higher cardiovascular disease prevalence and mortality among younger blacks compared to whites. Am J Med 123:811\u2013818","journal-title":"Am J Med"},{"key":"2697_CR17","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s10549-012-2142-1","volume":"134","author":"MP Banegas","year":"2012","unstructured":"Banegas MP, Li C (2012) Breast cancer characteristics and outcomes among Hispanic black and Hispanic white women. Breast Cancer Res Treat 134:1297\u20131304","journal-title":"Breast Cancer Res Treat"},{"key":"2697_CR18","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1158\/0008-5472.CAN-06-1927","volume":"66","author":"K Amend","year":"2006","unstructured":"Amend K, Hicks D, Ambrosone CB (2006) Breast cancer in African-American women: differences in tumor biology from European-American women. Cancer Res 66:8327\u20138330","journal-title":"Cancer Res"},{"key":"2697_CR19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1023\/A:1015220420400","volume":"73","author":"SA Joslyn","year":"2002","unstructured":"Joslyn SA (2002) Hormone receptors in breast cancer: racial differences in distribution and survival. Breast Cancer Res Treat 73:45\u201359","journal-title":"Breast Cancer Res Treat"},{"key":"2697_CR20","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10549-010-1191-6","volume":"127","author":"SL Ooi","year":"2011","unstructured":"Ooi SL, Martinez ME, Li CI (2011) Disparities in breast cancer characteristics and outcomes by race\/ethnicity. Breast Cancer Res Treat 127:729\u2013738","journal-title":"Breast Cancer Res Treat"},{"key":"2697_CR21","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/jnci\/djr543","volume":"104","author":"JA Sparano","year":"2012","unstructured":"Sparano JA, Wang M, Zhao F, Stearns V, Martino S, Ligibel JA, Perez EA, Saphner T, Wolff AC, Sledge GW Jr, Wood WC, Davidson NE (2012) Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial. J Natl Cancer Inst 104:406\u2013414","journal-title":"J Natl Cancer Inst"},{"key":"2697_CR22","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/cncr.25746","volume":"117","author":"CK Anders","year":"2011","unstructured":"Anders CK, Deal AM, Miller CR, Khorram C, Meng H, Burrows E, Livasy C, Fritchie K, Ewend MG, Perou CM, Carey LA (2011) The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases. Cancer 117:1602\u20131611","journal-title":"Cancer"},{"key":"2697_CR23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jss.2007.03.085","volume":"143","author":"CU Ihemelandu","year":"2007","unstructured":"Ihemelandu CU, Leffall LD Jr, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA (2007) Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival. J Surg Res 143:109\u2013118","journal-title":"J Surg Res"},{"key":"2697_CR24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10549-008-9926-3","volume":"113","author":"MJ Lund","year":"2009","unstructured":"Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, Flagg EW, O\u2019Regan RM, Gabram SG, Eley JW (2009) Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat 113:357\u2013370","journal-title":"Breast Cancer Res Treat"},{"key":"2697_CR25","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/ijc.27326","volume":"131","author":"JD Fackenthal","year":"2012","unstructured":"Fackenthal JD, Zhang J, Zhang B, Zheng Y, Hagos F, Burrill DR, Niu Q, Huo D, Sveen WE, Ogundiran T, Adebamowo C, Odetunde A, Falusi AG, Olopade OI (2012) High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients. Int J Cancer 131:1114\u20131123","journal-title":"Int J Cancer"},{"key":"2697_CR26","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/cncr.20500","volume":"101","author":"BA Jones","year":"2004","unstructured":"Jones BA, Kasl SV, Howe CL, Lachman M, Dubrow R, Curnen MM, Soler-Vila H, Beeghly A, Duan F, Owens P (2004) African-American\/White differences in breast carcinoma: p53 alterations and other tumor characteristics. Cancer 101:1293\u20131301","journal-title":"Cancer"},{"key":"2697_CR27","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1186\/bcr1844","volume":"10","author":"Y Wu","year":"2008","unstructured":"Wu Y, Mohamed H, Chillar R, Ali I, Clayton S, Slamon D, Vadgama JV (2008) Clinical significance of Akt and HER2\/neu overexpression in African-American and Latina women with breast cancer. Breast Cancer Res 10:R3","journal-title":"Breast Cancer Res"},{"key":"2697_CR28","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1200\/JCO.2005.02.4091","volume":"23","author":"E Tan-Chiu","year":"2005","unstructured":"Tan-Chiu E, Yothers G, Romond E, Geyer CE Jr, Ewer M, Keefe D, Shannon RP, Swain SM, Brown A, Fehrenbacher L, Vogel VG, Seay TE, Rastogi P, Mamounas EP, Wolmark N, Bryant J (2005) Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31. J Clin Oncol 23:7811\u20137819","journal-title":"J Clin Oncol"},{"key":"2697_CR29","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1002\/cncr.25854","volume":"117","author":"XL Du","year":"2011","unstructured":"Du XL, Lin CC, Johnson NJ, Altekruse S (2011) Effects of individual-level socioeconomic factors on racial disparities in cancer treatment and survival: findings from the National Longitudinal Mortality Study, 1979\u20132003. Cancer 117:3242\u20133251","journal-title":"Cancer"},{"key":"2697_CR30","first-page":"118","volume":"4","author":"O Abidoye","year":"2007","unstructured":"Abidoye O, Ferguson MK, Salgia F (2007) Lung carcinoma in African Americans. Nature 4:118\u2013129","journal-title":"Nature"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-013-2697-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-013-2697-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-013-2697-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T22:52:57Z","timestamp":1553640777000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-013-2697-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,24]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["2697"],"URL":"https:\/\/doi.org\/10.1007\/s10549-013-2697-5","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,24]]}}}